Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 08, 2022

SELL
$278.73 - $327.27 $95,883 - $112,580
-344 Closed
0 $0
Q1 2022

Apr 12, 2022

BUY
$234.69 - $291.66 $13,142 - $16,332
56 Added 19.44%
344 $99,000
Q4 2021

Jan 18, 2022

BUY
$224.85 - $279.04 $64,756 - $80,363
288 New
288 $80,000
Q2 2021

Jul 16, 2021

SELL
$180.55 - $233.54 $928,568 - $1.2 Million
-5,143 Closed
0 $0
Q1 2021

Apr 09, 2021

BUY
$164.32 - $212.72 $845,097 - $1.09 Million
5,143 New
5,143 $961,000
Q4 2020

Jan 11, 2021

SELL
$130.46 - $172.63 $980,406 - $1.3 Million
-7,515 Closed
0 $0
Q3 2020

Oct 23, 2020

BUY
$146.22 - $169.13 $87,732 - $101,478
600 Added 8.68%
7,515 $1.11 Million
Q2 2020

Jul 13, 2020

BUY
$136.42 - $164.18 $650,723 - $783,138
4,770 Added 222.38%
6,915 $1.06 Million
Q1 2020

Apr 14, 2020

BUY
$119.05 - $147.35 $252,624 - $312,676
2,122 Added 9226.09%
2,145 $298,000
Q4 2019

Jan 31, 2020

SELL
$106.92 - $132.43 $197,053 - $244,068
-1,843 Reduced 98.77%
23 $3,000
Q3 2019

Oct 15, 2019

SELL
$106.79 - $116.16 $424,597 - $461,852
-3,976 Reduced 68.06%
1,866 $207,000
Q2 2019

Jul 18, 2019

BUY
$110.79 - $129.32 $642,138 - $749,538
5,796 Added 12600.0%
5,842 $647,000
Q1 2019

Apr 11, 2019

SELL
$111.31 - $131.02 $17,586 - $20,701
-158 Reduced 77.45%
46 $6,000
Q4 2018

Jan 22, 2019

SELL
$105.9 - $118.64 $4,871 - $5,457
-46 Reduced 18.4%
204 $24,000
Q3 2018

Oct 23, 2018

BUY
$85.86 - $107.31 $20,434 - $25,539
238 Added 1983.33%
250 $27,000
Q2 2018

Aug 01, 2018

BUY
$75.7 - $86.88 $908 - $1,042
12 New
12 $1,000
Q1 2018

May 02, 2018

SELL
$74.21 - $87.6 $1.14 Million - $1.34 Million
-15,298 Closed
0 $0
Q4 2017

Feb 07, 2018

BUY
$81.94 - $87.89 $1.25 Million - $1.34 Million
15,298
15,298 $1.29 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $834B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Nu Wave Investment Management, LLC Portfolio

Follow Nu Wave Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nu Wave Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nu Wave Investment Management, LLC with notifications on news.